18q21 rearrangement in diffuse large cell lymphoma: Incidence and clinical significance Journal Article


Authors: Offit, K.; Koduru, P. R. K.; Hollis, R.; Filippa, D.; Jhanwar, S. C.; Clarkson, B. C.; Chaganti, R. S. K.
Article Title: 18q21 rearrangement in diffuse large cell lymphoma: Incidence and clinical significance
Abstract: Summary. Cytogenetic, molecular genetic and clinical information was collected for 102 cases of diffuse large cell lymphoma (DLCL) ascertained in a diagnostic laboratory over a 3‐year period. Nineteen cases showed evidence of either a t(14;18) or a rearrangement of one of three genomic probes for breakpoints at 18q21. Clinical and histologic evidence of transformation from follicular lymphoma or chronic lymphocytic leukaemia was available in six cases. Except for age, prognostic clinical variables (LDH, stage, extranodal involvement) were similar between the 18q21 rearranged patients and DLCL patients without 18q21 rearrangement. At a median follow‐up in excess of 2 years for both groups, there was no difference in overall survival between the 18q21 rearranged group compared to DLCL patients lacking this genetic abnormality. The median disease‐free survival for the 18q21 rearranged group, however, was significantly shorter and survival in partial remission longer. The propensity for extended survival of the 18q21 rearranged DLCL patients with residual or recurrent disease resembled the clinical behaviour of nodular lymphoma patients with t(14;18). These results suggest that cytogenic or molecular genetic identification of a chromosome 18q21 translocation may be of prognostic significance in the analysis of treatment protocols for patients with DLCL. Copyright © 1989, Wiley Blackwell. All rights reserved
Keywords: adult; clinical article; aged; histology; gene rearrangement; genetic engineering; lymphoma, non-hodgkin; chromosome translocation; large cell lymphoma; fatality; middle age; chromosomes, human, pair 14; chromosomes, human, pair 18; prognosis; human; male; female; priority journal; support, u.s. gov't, p.h.s.; translocation (genetics)
Journal Title: British Journal of Haematology
Volume: 72
Issue: 2
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 1989-01-01
Start Page: 178
End Page: 183
Language: English
DOI: 10.1111/j.1365-2141.1989.tb07680.x
PUBMED: 2757964
PROVIDER: scopus
DOI/URL:
Notes: Article -- Author Bayard D. Clarkson's middle initial is incorrect on the original publication -- Export Date: 14 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    788 Offit
  2. Daniel A Filippa
    148 Filippa
  3. Raju S K Chaganti
    391 Chaganti
  4. Suresh C Jhanwar
    293 Jhanwar
  5. Bayard Clarkson
    220 Clarkson
  6. Prasad R. K. Koduru
    17 Koduru